NO872331L - Farmasoeytiske preparater for behandling av bakterielle infeksjoner. - Google Patents

Farmasoeytiske preparater for behandling av bakterielle infeksjoner.

Info

Publication number
NO872331L
NO872331L NO872331A NO872331A NO872331L NO 872331 L NO872331 L NO 872331L NO 872331 A NO872331 A NO 872331A NO 872331 A NO872331 A NO 872331A NO 872331 L NO872331 L NO 872331L
Authority
NO
Norway
Prior art keywords
bacterial infections
pharmaceutical preparations
treating bacterial
preparation
esters
Prior art date
Application number
NO872331A
Other languages
English (en)
Norwegian (no)
Other versions
NO872331D0 (no
Inventor
Michael Limbert
Elmar Schrinner
Gerhard Seibert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO872331D0 publication Critical patent/NO872331D0/no
Publication of NO872331L publication Critical patent/NO872331L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO872331A 1986-06-04 1987-06-03 Farmasoeytiske preparater for behandling av bakterielle infeksjoner. NO872331L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863618813 DE3618813A1 (de) 1986-06-04 1986-06-04 Pharmazeutische zubereitung zur behandlung bakterieller infektionen

Publications (2)

Publication Number Publication Date
NO872331D0 NO872331D0 (no) 1987-06-03
NO872331L true NO872331L (no) 1987-12-07

Family

ID=6302277

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872331A NO872331L (no) 1986-06-04 1987-06-03 Farmasoeytiske preparater for behandling av bakterielle infeksjoner.

Country Status (27)

Country Link
US (1) US4919932A (pt)
EP (1) EP0248361B1 (pt)
JP (1) JPS62292721A (pt)
CN (1) CN87104023A (pt)
AR (1) AR241305A1 (pt)
AT (1) ATE71299T1 (pt)
AU (1) AU597068B2 (pt)
CA (1) CA1294217C (pt)
DD (1) DD257015A5 (pt)
DE (2) DE3618813A1 (pt)
DK (1) DK166759B1 (pt)
EG (1) EG18213A (pt)
ES (1) ES2035829T3 (pt)
FI (1) FI872459A (pt)
GR (1) GR3003856T3 (pt)
HU (1) HU199288B (pt)
IL (1) IL82767A (pt)
MA (1) MA20994A1 (pt)
MY (1) MY101079A (pt)
NO (1) NO872331L (pt)
NZ (1) NZ220509A (pt)
OA (1) OA08609A (pt)
PH (1) PH26214A (pt)
PL (1) PL266058A1 (pt)
PT (1) PT84996B (pt)
TN (1) TNSN87077A1 (pt)
ZA (1) ZA873970B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231487B (it) * 1988-10-24 1991-12-07 Erba Carlo Spa Composizione sinergica antibatterica contenente penem e ceftizoximaf
DE69019395D1 (de) * 1989-02-21 1995-06-22 Banyu Pharma Co Ltd Zusammensetzung gegen Mikroben.
DE3909056A1 (de) * 1989-03-18 1990-09-20 Hoechst Ag Pharmazeutische kombinationspraeparate und deren verwendung zur prophylaxe oder behandlung bakterieller infektionskrankheiten
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
EP0041768B1 (en) * 1980-04-24 1987-11-11 Beecham Group Plc Beta-lactam compounds, their preparation and use
ES8305366A1 (es) * 1981-07-08 1983-04-01 Hoechst Uk Ltd "procedimiento para la preparacion de derivados de penem".
EP0120613A1 (en) * 1983-03-02 1984-10-03 Beecham Group Plc Penem derivatives and precursors
DE3424144A1 (de) * 1984-06-30 1986-01-09 Bayer Ag, 5090 Leverkusen Verfahren zur erhoehung der bruchfestigkeit von granalien

Also Published As

Publication number Publication date
PT84996B (pt) 1990-03-08
JPS62292721A (ja) 1987-12-19
AU7379587A (en) 1987-12-10
FI872459A (fi) 1987-12-05
AU597068B2 (en) 1990-05-24
IL82767A (en) 1992-09-06
ZA873970B (en) 1987-12-02
AR241305A1 (es) 1992-05-29
DE3618813A1 (de) 1987-12-10
IL82767A0 (en) 1987-12-20
EP0248361B1 (de) 1992-01-08
DD257015A5 (de) 1988-06-01
MY101079A (en) 1991-07-16
GR3003856T3 (pt) 1993-03-16
MA20994A1 (fr) 1987-12-31
FI872459A0 (fi) 1987-06-02
HU199288B (en) 1990-02-28
US4919932A (en) 1990-04-24
NZ220509A (en) 1989-11-28
PT84996A (de) 1987-07-01
DK284787A (da) 1987-12-05
TNSN87077A1 (fr) 1990-01-01
ES2035829T3 (es) 1993-05-01
NO872331D0 (no) 1987-06-03
DK284787D0 (da) 1987-06-03
PH26214A (en) 1992-03-18
DE3775823D1 (de) 1992-02-20
EG18213A (en) 1992-09-30
ATE71299T1 (de) 1992-01-15
EP0248361A2 (de) 1987-12-09
EP0248361A3 (en) 1989-09-06
DK166759B1 (da) 1993-07-12
OA08609A (fr) 1988-11-30
PL266058A1 (en) 1988-07-21
CA1294217C (en) 1992-01-14
HUT44926A (en) 1988-05-30
CN87104023A (zh) 1988-03-09

Similar Documents

Publication Publication Date Title
NO972475L (no) Ny antitrombotisk formulering, fremgangsmåte for dens fremstilling og anvendelse derav
DE69027865T2 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
DE59509751D1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
CS149192A3 (en) Pharmaceutical composition, process of its preparation and method offungal infections treating
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
DE3782346T2 (de) Verwendung von chinolon und naphthyridin-antibiotika zur herstellung von ophthalmischen arzneimitteln.
NO171723C (no) Fremgangsmaate for fremstilling av pentamidinsalter, nyttige i behandling av profylakse av pneumocystis carinii pneumonia
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
NO872331L (no) Farmasoeytiske preparater for behandling av bakterielle infeksjoner.
LTIP1534A (en) Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin
BR9708864A (pt) Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
IE870577L (en) Topical amide preparation
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
EP0286802A3 (en) Use of ofloxacin in treating or preventing locally periodontal disease
NO990283L (no) Formulering for behandling og/eller profylakse av demens
EP0297523A3 (de) Verfahren zur Herstellung von Elaiophylin und dessen Verwendung
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DK192487D0 (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.